Antibody Therapeutics against HIV-1 – Advances and Obstacles
Boris Juelg, MD, Ph.D., Group Leader, Ragon Institute of MGH, MIT and Harvard, Infectious Diseases Division, MGH, CVVR, BIDMC
Boris Juelg, MD, Ph.D., Group Leader, Ragon Institute of MGH, MIT and Harvard, Infectious Diseases Division, MGH, CVVR, BIDMC
Christy L. Lavine, Ph.D., Staff Scientist in Dolin/Seaman Lab , Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School
Jinyan Liu, M.D., Ph.D., Staff Scientist in the Barouch Lab, Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School
Sizun Jiang ,Ph.D., Principal Investigator, Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Affiliate Faculty, Department of Oncologic Pathology , Dana Farber Cancer Institute
Steven D. Freedman M.D., Ph.D., Professor of Medicine, Harvard Medical School Director, Harvard Catalyst Grant Review and Support Program (GRASP) Beth Israel Deaconess Medical Center Chief, Division of Translational Research Director, The Pancreas Center Director, BIDMC Internal Medicine Physician-Scientist Track & Epstein Society Boston Children's Hospital Division of Respiratory Diseases | Cystic Fibrosis Center
Barney Graham, M.D., Ph.D., Deputy Director Emeritus, Vaccine Research Center, Chief Emeritus, Viral Pathogenesis Laboratory, National Institutes of Health
Ali Ellebedy, Ph.D., Associate Professor of Pathology and Immunology, Co-Director, Center for Vaccines and Immunity to Microbial Pathogens (CVIMP), Washington University School of Medicine
Presentation: Translational Clinical Research for HIV and COVID-19 Vaccine Development Speaker: Katy Stephenson, M.D., M.P.H., Principal Investigator and CTU Principal Investigator Clinical Trials Unit, Assistant Professor of Medicine, Harvard Medical School, Ragon Institute of MGH, MIT, and Harvard
Presentation: Clinical Studies of anti-HIV antibodies 3BNC117 and 10-1074 Speaker: Marina Caskey, M.D., Professor of Clinical Investigation, The Rockefeller University
Presents: “Virological and immunological characteristics of SARS-CoV-2 variants”